FI971151A0 - Kolesterolin absorption inhibiittorin ja kolesterolin synteesin inhibiittorin yhdistelmä - Google Patents

Kolesterolin absorption inhibiittorin ja kolesterolin synteesin inhibiittorin yhdistelmä

Info

Publication number
FI971151A0
FI971151A0 FI971151A FI971151A FI971151A0 FI 971151 A0 FI971151 A0 FI 971151A0 FI 971151 A FI971151 A FI 971151A FI 971151 A FI971151 A FI 971151A FI 971151 A0 FI971151 A0 FI 971151A0
Authority
FI
Finland
Prior art keywords
cholesterol
inhibitor
combination
cholesterol absorption
synthesis inhibitor
Prior art date
Application number
FI971151A
Other languages
English (en)
Swedish (sv)
Other versions
FI971151A (fi
Inventor
Lee A Morehouse
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI971151A0 publication Critical patent/FI971151A0/fi
Publication of FI971151A publication Critical patent/FI971151A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI971151A 1994-09-20 1997-03-19 Kolesterolin absorption inhibiittorin ja kolesterolin synteesin inhibiittorin yhdistelmä FI971151A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30890894A 1994-09-20 1994-09-20
PCT/IB1995/000447 WO1996009827A2 (en) 1994-09-20 1995-06-07 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor

Publications (2)

Publication Number Publication Date
FI971151A0 true FI971151A0 (fi) 1997-03-19
FI971151A FI971151A (fi) 1997-03-19

Family

ID=23195885

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971151A FI971151A (fi) 1994-09-20 1997-03-19 Kolesterolin absorption inhibiittorin ja kolesterolin synteesin inhibiittorin yhdistelmä

Country Status (12)

Country Link
US (1) US5807834A (fi)
EP (1) EP0782451A1 (fi)
JP (1) JPH09511753A (fi)
AU (1) AU2453295A (fi)
BR (1) BR9504072A (fi)
CA (1) CA2200436A1 (fi)
FI (1) FI971151A (fi)
HR (1) HRP950488A2 (fi)
IL (1) IL115310A0 (fi)
MX (1) MX9702175A (fi)
WO (1) WO1996009827A2 (fi)
ZA (1) ZA957879B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7948394A (en) * 1993-12-28 1995-07-17 Pfizer Inc. Hypocholesterolemic agents
SK158795A3 (en) * 1994-12-23 1997-01-08 Pfizer Benzazepines and pharmaceutical compositions on their base
US5965553A (en) * 1996-06-20 1999-10-12 Pfizer Inc. Squalene synthetase inhibitors
AU2401697A (en) * 1996-06-20 1998-01-07 Pfizer Inc. 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors
WO1998047882A1 (en) 1997-04-21 1998-10-29 Takeda Chemical Industries, Ltd. 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
US6180660B1 (en) * 1997-08-26 2001-01-30 Merck & Co., Inc. Cholesterol-lowering therapy
US20030153541A1 (en) * 1997-10-31 2003-08-14 Robert Dudley Novel anticholesterol compositions and method for using same
JP3768100B2 (ja) * 1998-03-26 2006-04-19 ファイトファーム・ピーエルシー アルツハイマー病を治療するためのステロイドサポゲニンとその誘導体
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6207664B1 (en) 1998-11-25 2001-03-27 Pfizer Inc. Squalene synthetase inhibitor agents
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6465011B2 (en) 1999-05-29 2002-10-15 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
US20030092745A1 (en) * 2000-02-25 2003-05-15 Pfizer Inc. Combination therapy
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
PT1558627E (pt) * 2002-10-28 2010-05-06 Phytopharm Plc Reduçao estereoespecífica de sapogen-3-onas
ATE406364T1 (de) 2003-03-07 2008-09-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
ES2318274T3 (es) 2003-03-07 2009-05-01 Schering Corporation Compuestos de azetidinona sustituida, formulaciones y uso de los mismos para el tratamiento de hipercolesterolemia.
WO2005051298A2 (en) 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
BRPI0418004A (pt) 2003-12-23 2007-04-17 Astrazeneca Ab composto ou um sal, solvato, solvato de um tal sal ou uma pró-droga deste farmaceuticamente aceitáveis, métodos para tratar ou prevenir condições hiperlipidêmicas, aterosclerose, mal de alzheimer, e tumores associados com colesterol, formulação farmacêutica, combinação, e, processo para preparar um composto ou um sal, solvato, solvato de um tal sal ou uma pró-droga deste farmaceuticamente aceitáveis
JP4477474B2 (ja) * 2004-11-15 2010-06-09 株式会社日立製作所 糞便懸濁ろ過用容器
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
WO2007048027A2 (en) 2005-10-21 2007-04-26 Novartis Ag Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
US5063210A (en) * 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
SK158394A3 (en) * 1992-06-26 1995-05-10 Pfizer Steroidal glycosides
LT3300B (en) * 1992-12-23 1995-06-26 Schering Corp Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor

Also Published As

Publication number Publication date
ZA957879B (en) 1997-03-19
MX9702175A (es) 1997-06-28
JPH09511753A (ja) 1997-11-25
EP0782451A1 (en) 1997-07-09
US5807834A (en) 1998-09-15
HRP950488A2 (en) 1997-08-31
CA2200436A1 (en) 1996-04-04
IL115310A0 (en) 1995-12-31
WO1996009827A2 (en) 1996-04-04
WO1996009827A3 (en) 1996-05-23
FI971151A (fi) 1997-03-19
AU2453295A (en) 1996-04-19
BR9504072A (pt) 1996-07-30

Similar Documents

Publication Publication Date Title
FI971151A0 (fi) Kolesterolin absorption inhibiittorin ja kolesterolin synteesin inhibiittorin yhdistelmä
LV11178A (lv) 3-Ú4-(2-aminoetoksi) benzoil¾-2-aril-6-hidroksibenzoÚb¾tiofenu sintezes panemiens
DE69603713D1 (de) Haftkleber und bänder
DE69500727D1 (de) Klebstoffmischung und Faser-Gummi-Verbundwerkstoff
FI964267A (fi) Porfosyaniini ja CNC-laajennetut porfyriinit
FI970828A0 (fi) Spirostanyyliglykosidien kiteitä
DE69600076D1 (de) Schalldämmendes und stossfestes Zaunpanel
FI950561A0 (fi) Ryömykestävä rauta-kromi-alumiiniseos ja siitä valmistettu tuote
DE69502429D1 (de) Auflösung von Gas
FI974332A (fi) Menetelmä kerroselementin valmistamiseksi ja kerroselementti
FR2729984B3 (fr) Panneau d'absorption accoustique
DE69602782D1 (de) Klebstoffzusammensetzung und ihre Verwendung
KR960022883U (ko) 하니콤 패널
KR960009588U (ko) 피씨비와 샤시의 결합구조
NO972917D0 (no) Korrugerte konstruksjoner og en profilert labank til bruk i slike konstruksjoner
KR950030576U (ko) 판넬의 조립구조
KR970005433A (ko) 판넬의 플랜지길이 결정방법
EE9400258A (et) Kombinatsioonpreparaadid p- hüdroksübensoehappe derivaadi ja HMG- CoA- reduktaasi pärssija sisaldusega
NO961849D0 (no) Absorpsjon av merkaptaner
IL110191A0 (en) Absorption of odors
GB9508604D0 (en) Topical application of ceramides
KR950032528U (ko) 기구용 판넬
KR950005606U (ko) 두루마리화장지
KR970004616U (ko) 덕트의 흡음 부재
AU125731S (en) A set of panel sections

Legal Events

Date Code Title Description
FD Application lapsed